Details for: SERAC1
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 3.42rCSI 6.87%PRS 89.03
-
CSI 3.3rCSI 5.55%PRS 83.81
-
CSI 3.28rCSI 3.44%PRS 94.74
-
CSI 3.27rCSI 3.21%PRS 94.58
-
CSI 2.6rCSI 4.5%PRS 89.67
-
CSI 2.6rCSI 5.83%PRS 84.02
-
CSI 2.42rCSI 4.53%PRS 87.04
-
CSI 2.21rCSI 2%PRS 92.68
-
CSI 2.01rCSI 2.4%PRS 83.76
-
CSI 1.95rCSI 2.43%PRS 81.61
-
CSI 1.88rCSI 3.81%PRS 78.96
-
CSI 1.83rCSI 2.36%PRS 84.69
-
CSI 1.83rCSI 4.76%PRS 88.59
-
CSI 1.65rCSI 14.18%PRS 87.32
-
CSI 1.53rCSI 3.15%PRS 83.82
-
CSI 1.52rCSI 2.68%PRS 83.16
-
CSI 1.42rCSI 4.1%PRS 86.89
-
CSI 1.36rCSI 3%PRS 85.33
-
CSI 1.3rCSI 3.47%PRS 89.87
-
CSI 1.26rCSI 2.03%PRS 84.71
-
CSI 1.21rCSI 2.36%PRS 94.55
-
CSI 1.17rCSI 2.84%PRS 81.61
-
CSI 0.99rCSI 15.67%PRS 93.79
-
CSI 0.78rCSI 4.4%PRS 84.98
-
CSI 0.74rCSI 2.81%PRS 83.89
-
CSI 0.73rCSI 3.17%PRS 93.79
-
CSI 0.65rCSI 2.04%PRS 86.57
-
CSI 0.63rCSI 1.97%PRS 84.75
-
CSI 0.61rCSI 2.2%PRS 81.92
-
CSI 0.38rCSI 2.23%PRS 84.07
-
CSI 0.38rCSI 9.08%PRS 81.55
-
CSI 0.29rCSI 6.83%PRS 81.57
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 514593898
Symbol: SRAC1_HUMAN
Name: Protein SERAC1
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 14574404
Title: The DNA sequence and analysis of human chromosome 6.
PubMed ID: 14574404
DOI: 10.1038/nature02055
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 23707711
Title: Exome sequencing identifies a new mutation in SERAC1 in a patient with 3-methylglutaconic aciduria.
PubMed ID: 23707711
PubMed ID: 22683713
Title: Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness.
PubMed ID: 22683713
DOI: 10.1038/ng.2325
PubMed ID: 28778788
Title: Novel mutations in SERAC1 gene in two Indian patients presenting with dystonia and intellectual disability.
PubMed ID: 28778788
Sequence Information:
- Length: 654
- Mass: 74147
- Checksum: B40F3B41C0FBEDDE
- Sequence:
MSLAAYCVIC CRRIGTSTSP PKSGTHWRDI RNIIKFTGSL ILGGSLFLTY EVLALKKAVT LDTQVVEREK MKSYIYVHTV SLDKGENHGI AWQARKELHK AVRKVLATSA KILRNPFADP FSTVDIEDHE CAVWLLLRKS KSDDKTTRLE AVREMSETHH WHDYQYRIIA QACDPKTLIG LARSEESDLR FFLLPPPLPS LKEDSSTEEE LRQLLASLPQ TELDECIQYF TSLALSESSQ SLAAQKGGLW CFGGNGLPYA ESFGEVPSAT VEMFCLEAIV KHSEISTHCD KIEANGGLQL LQRLYRLHKD CPKVQRNIMR VIGNMALNEH LHSSIVRSGW VSIMAEAMKS PHIMESSHAA RILANLDRET VQEKYQDGVY VLHPQYRTSQ PIKADVLFIH GLMGAAFKTW RQQDSEQAVI EKPMEDEDRY TTCWPKTWLA KDCPALRIIS VEYDTSLSDW RARCPMERKS IAFRSNELLR KLRAAGVGDR PVVWISHSMG GLLVKKMLLE ASTKPEMSTV INNTRGIIFY SVPHHGSRLA EYSVNIRYLL FPSLEVKELS KDSPALKTLQ DDFLEFAKDK NFQVLNFVET LPTYIGSMIK LHVVPVESAD LGIGDLIPVD VNHLNICKPK KKDAFLYQRT LQFIREALAK DLEN